Toxic multinodular goiter historical perspective

Jump to navigation Jump to search

Toxic multinodular goiter Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Toxic multinodular goiter from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Toxic multinodular goiter historical perspective On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Toxic multinodular goiter historical perspective

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Toxic multinodular goiter historical perspective

CDC on Toxic multinodular goiter historical perspective

Toxic multinodular goiter historical perspective in the news

Blogs on Toxic multinodular goiter historical perspective

Directions to Hospitals Treating Toxic multinodular goiter

Risk calculators and risk factors for Toxic multinodular goiter historical perspective

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Akshun Kalia M.B.B.S.[2]

Overview

In the year 40 BC, Pliny, Vitruvius, and Juvenal were the first who documented the prevalence of goiter in the Alps. In 1500, Leonardo da Vinci was the first who recognized and drew the thyroid gland. In 1913, Henry Plummer, an American physician was the first to describe toxic multinodular goiter or Plummer's disease. In 1947, Cope, Rawson, and McArthur were the first who described the usage of radioactive iodine to demonstrate a "hot" thyroid nodule.

Historical Perspective

The historical perspective of toxic multinodular goiter is as below:[1][2][3]

  • In 40 BC, Pliny, Vitruvius, and Juvenal were the first who documented the prevalence of goiter in the Alps.
  • In 138, Soranus, a Greek physician, reported a case of neck swelling following pregnancy.
  • In 1500, Leonardo da Vinci was the first who recognized and drew the thyroid gland.
  • In 1543, Andreas Vesalius, Belgian physician was the first to provide anatomic description and illustration of the thyroid gland in his article 'De humani corporis Fabrica libri septem'.
  • In 1563, Eustachius was the first who introduced the term "isthmus" to describe tissue connecting the two lobes of the thyroid gland.
  • In 1834, Robert Graves was the first who described a syndrome of palpitation, goiter, and exophthalmos.
  • In 1913, Henry Plummer, an American physician was the first to describe toxic multinodular goiter or Plummer's disease.
  • In 1936, Dr. Saul Hertz was the first who described the usage of radioactive iodine for the study of the thyroid gland.
  • In 1947, Cope, Rawson, and McArthur were the first who described the usage of radioactive iodine to demonstrate a "hot" thyroid nodule.
  • In 1948, T. Templa, J. Aleksandrowicz, and M. Till were the first who described the usage of fine needle thyroid biopsy as a diagnostic method for thyroid nodules.

References

  1. Template:WhoNamedIt2 eponymously named after Template:WhoNamedIt
  2. Steele L (2014). "Andreas Vesalius and his De humani corporis Fabrica libri septem". Vesalius. 20 (1): 5–10. PMID 25181775.
  3. Fahey FH, Grant FD, Thrall JH (2017). "Saul Hertz, MD, and the birth of radionuclide therapy". EJNMMI Phys. 4 (1): 15. doi:10.1186/s40658-017-0182-7. PMC 5407393. PMID 28451906.

Template:WH Template:WS